Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
The ERL was closely linked with the National Institute for Biological standards and Control and the Committee on Safety of Medicines, and represented on various DHSS and Medical Research Council committees concerned with immunisation.
Published on:
25 July, 2024
The Communicable Disease Report published the results of the CDSC surveillance scheme set up to monitor opportunistic infections and cases of Kaposi's sarcoma.
Published on:
25 July, 2024
The Microbiology of Food and the Environment and Communicable Disease division of the DHSS was responsible for the monitoring of infectious and communicable diseases, included those transmitted via blood transfusion and other blood products.
Published on:
25 July, 2024
The DHSS published a health circular which set out the main functions of the CDSC.
Published on:
25 July, 2024
Professor Palmer took up a post as regional epidemiologist for Wales. At the time, he was the only CDSC consultant epidemiologist in the regions. He was the first to be appointed through the CDSC training programme.
Published on:
25 July, 2024
CDSC Wales acted as an advisor to the Chief Medical Officer at the Welsh Office on the epidemiology and control of communicable diseases in Wales.
Published on:
25 July, 2024
After reorganisation, Northern Ireland set up four health and social service boards. There was no separate administration for family practitioner services. Instead, the functions typically associated with community health councils were carried out by district committees.
Published on:
25 July, 2024
After reorganisation, the Welsh Office combined the functions of a central government department and a regional health authority.
Published on:
25 July, 2024
The National Health Service (Scotland) Act 1972 established 15 health boards with no regional tier of administration. Local health councils were established to oversee family practitioner services.
Published on:
25 July, 2024
The Communicable Disease Surveillance Centre for Northern Ireland was established.
Published on:
25 July, 2024
The PHLS Working Party on Haemodialysis Units published a report which measured the use of immunoglobulin to prevent the spread of hepatitis.
Published on:
25 July, 2024
The renal unit at London Hospital published a document outlining the precautions taken to prevent hepatitis in the dialysis and transplantation unit.
Published on:
25 July, 2024
The World Health Organization Expert Committee on Hepatitis First Report published in the WHO Technical Report series recommended that "both infectious and serum hepatitis should be made compulsorily notifiable in all countries as soon as circumstances permit."
Published on:
25 July, 2024
The Advisory Group on Hepatitis and the Treatment of Chronic Renal Failure (known as the Rosenheim Committee) published the "Hepatitis and the Treatment of Chronic Renal Failure: Report of the Advisory Group 1970-1972". The Advisory Group was convened in 1970 by the DHSS to make recommendations in relation to hepatitis outbreaks in renal units.
Published on:
25 July, 2024
The PHLS authored the journal article "Decrease in the Incidence of Hepatitis in Dialysis Units associated with Prevention Programme" that was published in the "British Medical Journal".
Published on:
25 July, 2024
A letter to the Editor on primary pneumocystis carinii and cytomegalovirus infections was published by R M Du Bois et al in "The Lancet", reporting the first AIDS case in a British patient.
Published on:
25 July, 2024
Dr Galbraith wrote to venereologists and dermatologists in England and Wales seeking their "cooperation" in a trial clinical reporting system of Kaposi's sarcoma due to the "inadequacies of existing surveillance systems".
Published on:
25 July, 2024
Dr Galbraith wrote a letter to Dr Rizza of the Oxford Haemophilia Centre regarding the surveillance of AIDS and Kaposi's sarcoma.
Published on:
25 July, 2024
Dr Rizza responded to Dr Galbraith, communicating his awareness of the CDSC's surveillance scheme from discussions with Dr Craske and readiness to "do all we can to help you with your surveillance".
Published on:
25 July, 2024
A letter to the Editor on acquired immune deficiency syndrome authored by O'Connor et al was published in the "British Medical Journal", asking all doctors to let CDSC know when a patient with AIDS or Kaposi's sarcoma came under their care.
Published on:
25 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2087
Page
2088
Page
2089
Page
2090
Current page
2091
Page
2092
Page
2093
Page
2094
Page
2095
…
Next page
Next
Last page
Last